ARCHIVES

NCI Director and Acting FDA Commissioner Andrew von Eschenbach Endorses Rep. E. Clay Shaw In Tour of Florida Congressman’s District. Von Eschenbach Praises Shaw’s “Leadership” In Seeking Funding For Research, Support of 2015 Goal.

This article is from The Cancer Letter archive.

Vol. 32 No. 04 | February 3, 2006

Download PDF Visit The Full Archive

Related Articles

Reinventing NCI: Natural Products Screen Closes; NCI Targets Drug Resistance

December 13, 1996

Guideline Revisions or Outstanding Investigator Grant Still Controversial

December 9, 1983

Eight States Get Cervical Cancer Screening Planning Contracts

June 21, 1974

In Brief: Unsolicited Proposals ‘Very Valuable,” DeVita Says, Asks Investigators To Keep Channel Open

April 18, 1975

Nurses Pass Resolution To Support Research on Ethnic Patient Issues

May 29, 1992

Vanderbilt-Ingram Cancer Center Wins NCI’s Comprehensive Designation.

March 16, 2001